Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Larry Dumont

Concepts (333)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Blood Preservation
48
2025
346
10.410
Why?
Blood Platelets
31
2024
379
8.350
Why?
Platelet Transfusion
19
2023
77
3.530
Why?
Erythrocytes
25
2025
748
3.450
Why?
Blood Donors
13
2021
144
2.850
Why?
Cryopreservation
11
2023
113
2.850
Why?
Plateletpheresis
11
2024
28
2.130
Why?
Antibodies, Viral
9
2025
674
1.530
Why?
Dimethyl Sulfoxide
3
2023
42
1.180
Why?
Platelet-Rich Plasma
2
2023
41
1.090
Why?
Plasma
6
2014
223
1.070
Why?
Pharmaceutical Solutions
4
2014
14
1.020
Why?
Antibodies, Neutralizing
8
2025
340
1.010
Why?
Leukocyte Reduction Procedures
8
2025
29
0.970
Why?
Mannitol
4
2014
40
0.950
Why?
Hydrogen-Ion Concentration
12
2024
531
0.950
Why?
Membrane Lipids
3
2020
82
0.930
Why?
Sodium Chloride
4
2014
138
0.890
Why?
Glucose
8
2017
1048
0.880
Why?
Blood Component Removal
5
2022
26
0.850
Why?
ABO Blood-Group System
5
2020
58
0.830
Why?
Adenine
4
2014
339
0.790
Why?
Metabolome
4
2020
388
0.760
Why?
Erythrocyte Transfusion
9
2021
225
0.720
Why?
Glycolysis
5
2021
340
0.660
Why?
Metformin
1
2024
329
0.660
Why?
Cytoskeleton
1
2022
192
0.650
Why?
Humans
91
2025
145475
0.640
Why?
Time Factors
21
2023
7123
0.630
Why?
Adenosine Triphosphate
6
2015
500
0.620
Why?
Solutions
4
2014
159
0.570
Why?
Immunization, Passive
10
2025
90
0.560
Why?
Hemostasis
3
2021
98
0.550
Why?
Erythrocyte Membrane
2
2020
55
0.540
Why?
Glutathione
2
2017
370
0.540
Why?
Carrier Proteins
1
2022
728
0.540
Why?
Blood Transfusion, Autologous
3
2020
18
0.530
Why?
Cold Temperature
3
2020
206
0.510
Why?
Blood Grouping and Crossmatching
3
2016
18
0.510
Why?
Cell Survival
10
2017
1100
0.460
Why?
Metabolomics
5
2021
732
0.450
Why?
Blood Group Incompatibility
2
2012
21
0.450
Why?
Leukocytes
3
2023
296
0.440
Why?
Dexamethasone
1
2017
365
0.440
Why?
Phosphatidylserines
2
2014
62
0.430
Why?
Cell-Derived Microparticles
2
2018
73
0.420
Why?
Drug Delivery Systems
1
2017
381
0.400
Why?
Carbon Dioxide
1
2015
227
0.400
Why?
Blood Safety
3
2016
11
0.400
Why?
Erythrocyte Aggregation
1
2012
4
0.380
Why?
Transfusion Reaction
3
2022
61
0.380
Why?
Blood Proteins
1
2014
239
0.370
Why?
Citrates
4
2017
41
0.370
Why?
Oxidative Stress
5
2020
1356
0.370
Why?
Dicarboxylic Acids
1
2011
12
0.350
Why?
Polyvinyl Chloride
1
2011
12
0.350
Why?
Diethylhexyl Phthalate
1
2011
13
0.350
Why?
Cyclohexanecarboxylic Acids
1
2011
19
0.350
Why?
Bacteriological Techniques
2
2013
66
0.350
Why?
United States Food and Drug Administration
3
2016
208
0.350
Why?
Catheterization, Peripheral
1
2012
120
0.330
Why?
Rejuvenation
1
2011
18
0.330
Why?
Minerals
1
2011
48
0.320
Why?
Platelet Aggregation
3
2022
99
0.320
Why?
Energy Metabolism
2
2021
935
0.320
Why?
Randomized Controlled Trials as Topic
4
2023
1747
0.320
Why?
Interferon Type I
2
2021
147
0.310
Why?
Staphylococcus epidermidis
1
2010
79
0.310
Why?
Urinary Tract Infections
1
2012
210
0.310
Why?
Bacteremia
1
2012
222
0.310
Why?
Evidence-Based Practice
1
2012
231
0.310
Why?
Hematopoietic Stem Cell Transplantation
2
2022
699
0.310
Why?
Oxygen
3
2015
978
0.300
Why?
Anaerobiosis
4
2015
65
0.280
Why?
Testosterone
3
2022
416
0.280
Why?
Thrombocytopenia
2
2022
204
0.280
Why?
Hemolysis
7
2025
242
0.280
Why?
Hemostatics
2
2021
64
0.270
Why?
Citric Acid
3
2012
33
0.270
Why?
Bacteria
2
2013
765
0.260
Why?
Platelet Activation
2
2024
99
0.250
Why?
Seroepidemiologic Studies
3
2021
171
0.250
Why?
In Vitro Techniques
4
2021
1048
0.250
Why?
Leukapheresis
1
2006
27
0.240
Why?
Staphylococcal Infections
1
2010
391
0.240
Why?
Blood Banks
4
2020
50
0.240
Why?
Photopheresis
2
2018
9
0.230
Why?
Lactic Acid
2
2024
295
0.230
Why?
Specimen Handling
1
2007
182
0.230
Why?
Platelet Function Tests
2
2022
35
0.230
Why?
Adenosine Diphosphate
2
2022
83
0.230
Why?
Temperature
3
2014
633
0.220
Why?
Blood Transfusion
4
2016
409
0.220
Why?
Blood Coagulation Tests
2
2015
72
0.220
Why?
Serologic Tests
2
2022
54
0.210
Why?
Oxygen Consumption
2
2024
718
0.210
Why?
Platelet Count
4
2020
94
0.210
Why?
Anticoagulants
4
2014
748
0.210
Why?
Leukocytes, Mononuclear
2
2023
574
0.210
Why?
Male
26
2025
72843
0.200
Why?
2,3-Diphosphoglycerate
2
2015
32
0.200
Why?
Autoantibodies
2
2021
1509
0.200
Why?
Hemoglobins
4
2022
386
0.190
Why?
P-Selectin
3
2022
29
0.190
Why?
Xenon
1
2022
7
0.190
Why?
Neuroacanthocytosis
1
2022
5
0.190
Why?
Furocoumarins
1
2022
8
0.190
Why?
Refrigeration
1
2022
11
0.190
Why?
HMGB1 Protein
1
2022
51
0.180
Why?
Adult
17
2025
40777
0.180
Why?
Hormone Replacement Therapy
2
2021
107
0.180
Why?
Granulomatous Disease, Chronic
1
2022
49
0.180
Why?
Flow Cytometry
1
2006
1162
0.180
Why?
Hospital Distribution Systems
1
2021
1
0.180
Why?
Compassionate Use Trials
1
2021
7
0.180
Why?
Female
21
2025
78845
0.170
Why?
Middle Aged
15
2025
36215
0.170
Why?
Radioisotopes
3
2008
37
0.170
Why?
Aged
13
2025
26153
0.160
Why?
Healthy Volunteers
2
2021
219
0.160
Why?
Bone Marrow Transplantation
1
2022
298
0.160
Why?
Organ Preservation Solutions
2
2012
46
0.160
Why?
Nonprescription Drugs
1
2021
69
0.160
Why?
Adolescent
8
2021
22530
0.160
Why?
Taurine
1
2020
41
0.150
Why?
Health Services Needs and Demand
1
2021
280
0.150
Why?
Prescription Drugs
1
2021
111
0.150
Why?
Antibodies, Monoclonal
2
2016
1505
0.140
Why?
Cryoprotective Agents
2
2018
11
0.140
Why?
Cooperative Behavior
3
2012
462
0.140
Why?
Asparagine
1
2018
35
0.140
Why?
Feasibility Studies
1
2023
1111
0.140
Why?
Freezing
1
2018
83
0.140
Why?
Oxidation-Reduction
3
2021
1067
0.140
Why?
Cigarette Smoking
1
2020
102
0.140
Why?
Aspartic Acid
1
2018
88
0.140
Why?
Product Packaging
2
2011
6
0.140
Why?
Blood Buffy Coat
1
2018
5
0.140
Why?
Host-Pathogen Interactions
1
2021
361
0.140
Why?
Buffers
2
2014
56
0.130
Why?
Lymphoma, T-Cell, Cutaneous
1
2018
45
0.130
Why?
Aged, 80 and over
5
2021
8333
0.130
Why?
Nicotine
1
2020
331
0.130
Why?
Extracorporeal Membrane Oxygenation
1
2021
390
0.130
Why?
Chromatography, Liquid
2
2021
450
0.130
Why?
Pentose Phosphate Pathway
1
2017
55
0.130
Why?
Immunoglobulin G
1
2021
892
0.120
Why?
Dithiothreitol
1
2016
19
0.120
Why?
Histocompatibility Testing
1
2016
123
0.120
Why?
Government Regulation
1
2016
39
0.120
Why?
Platelet Adhesiveness
1
2015
14
0.120
Why?
Severity of Illness Index
2
2021
2930
0.110
Why?
Guidelines as Topic
2
2020
266
0.110
Why?
Protein Processing, Post-Translational
1
2018
471
0.110
Why?
Transfusion Medicine
1
2015
18
0.110
Why?
Tandem Mass Spectrometry
2
2021
572
0.110
Why?
Heart-Assist Devices
1
2021
568
0.110
Why?
Young Adult
8
2021
14219
0.110
Why?
False Positive Reactions
2
2016
123
0.110
Why?
Cardiac Surgical Procedures
1
2021
610
0.110
Why?
Metabolic Networks and Pathways
1
2016
174
0.110
Why?
Monocytes
1
2018
539
0.110
Why?
Cross-Over Studies
3
2012
608
0.110
Why?
Therapeutic Equivalency
1
2014
31
0.110
Why?
Gases
1
2014
46
0.110
Why?
Hematocrit
1
2014
108
0.100
Why?
Osmolar Concentration
1
2014
168
0.100
Why?
United States
8
2021
16098
0.100
Why?
False Negative Reactions
2
2011
61
0.100
Why?
Colony Count, Microbial
2
2011
89
0.100
Why?
Blood Coagulation Factors
1
2014
71
0.100
Why?
Gas Chromatography-Mass Spectrometry
1
2014
124
0.100
Why?
Blood Coagulation
1
2015
274
0.100
Why?
Disease Progression
1
2021
2864
0.100
Why?
Hemorrhage
1
2018
822
0.090
Why?
Registries
1
2021
2406
0.090
Why?
Vaccination
1
2021
1426
0.090
Why?
Hematologic Neoplasms
2
2018
168
0.090
Why?
Phosphoric Acids
1
2012
14
0.090
Why?
Single-Blind Method
3
2021
318
0.090
Why?
Microscopy, Electron, Transmission
1
2012
156
0.090
Why?
Treatment Outcome
6
2025
11772
0.090
Why?
Nitrogen Mustard Compounds
1
2011
9
0.090
Why?
Bacteria, Aerobic
1
2011
7
0.090
Why?
Acridines
1
2011
9
0.090
Why?
Checklist
1
2012
110
0.090
Why?
Heparin
1
2012
247
0.080
Why?
Bacteria, Anaerobic
1
2011
25
0.080
Why?
Immunity, Humoral
2
2023
118
0.080
Why?
Klebsiella oxytoca
1
2010
1
0.080
Why?
Viridans Streptococci
1
2010
7
0.080
Why?
Serratia Infections
1
2010
8
0.080
Why?
Preservatives, Pharmaceutical
1
2011
28
0.080
Why?
Adaptive Immunity
2
2023
167
0.080
Why?
Serratia marcescens
1
2010
17
0.080
Why?
Klebsiella Infections
1
2010
26
0.080
Why?
Delphi Technique
1
2012
332
0.080
Why?
Kinetics
1
2014
1567
0.080
Why?
Consensus
1
2012
477
0.080
Why?
Sensitivity and Specificity
2
2022
1997
0.080
Why?
Cell Membrane
1
2014
707
0.080
Why?
Obesity
2
2020
3116
0.080
Why?
Erythrocyte Count
2
2007
21
0.080
Why?
Graft vs Host Disease
1
2012
279
0.080
Why?
Escherichia coli Infections
1
2010
125
0.080
Why?
Regression Analysis
1
2012
1001
0.080
Why?
RNA, Viral
2
2025
692
0.080
Why?
Analysis of Variance
1
2012
1300
0.070
Why?
Biopsy, Fine-Needle
1
2009
68
0.070
Why?
Drug Combinations
1
2011
396
0.070
Why?
Mice
5
2021
18329
0.070
Why?
Publishing
1
2010
114
0.070
Why?
Leukocyte Count
2
2007
316
0.070
Why?
Thyroid Nodule
1
2009
57
0.070
Why?
Lipids
1
2014
707
0.070
Why?
Genetic Heterogeneity
1
2009
66
0.070
Why?
Hospitalization
3
2025
2460
0.070
Why?
Thrombosis
1
2012
400
0.070
Why?
Safety Management
1
2009
125
0.070
Why?
Streptococcal Infections
1
2010
171
0.070
Why?
Mice, Inbred C57BL
2
2021
5983
0.070
Why?
Ultraviolet Rays
2
2022
384
0.060
Why?
Proteome
1
2012
514
0.060
Why?
Transportation
1
2007
57
0.060
Why?
Animals
6
2022
38030
0.060
Why?
Cell Separation
1
2007
305
0.060
Why?
Staphylococcus aureus
1
2010
451
0.060
Why?
Escherichia coli
1
2010
835
0.060
Why?
Research Design
1
2012
1137
0.060
Why?
Survival Analysis
1
2009
1374
0.060
Why?
Risk Assessment
2
2012
3747
0.060
Why?
Practice Guidelines as Topic
1
2012
1581
0.050
Why?
Genotype
1
2009
1852
0.050
Why?
Pregnancy
1
2017
7202
0.050
Why?
Prevalence
2
2021
2865
0.050
Why?
Quality Control
2
2016
161
0.050
Why?
Neutralization Tests
1
2023
76
0.050
Why?
Blood Gas Analysis
1
2003
81
0.050
Why?
CD40 Ligand
1
2022
40
0.050
Why?
Clinical Trials as Topic
1
2008
1061
0.050
Why?
Blood Cell Count
1
2002
55
0.050
Why?
Glycerol
1
2022
90
0.040
Why?
Prospective Studies
3
2022
8057
0.040
Why?
Spike Glycoprotein, Coronavirus
1
2023
129
0.040
Why?
Masculinity
1
2021
10
0.040
Why?
Retrospective Studies
4
2020
17291
0.040
Why?
Macaca mulatta
1
2022
186
0.040
Why?
Convalescence
1
2021
19
0.040
Why?
Thrombin
1
2022
172
0.040
Why?
Ranitidine
1
2021
14
0.040
Why?
Medically Underserved Area
1
2021
100
0.040
Why?
Phosphotransferases (Alcohol Group Acceptor)
1
2021
49
0.040
Why?
Public Health Surveillance
1
2021
83
0.040
Why?
Hematologic Tests
1
2020
22
0.040
Why?
Osmotic Pressure
1
2020
41
0.040
Why?
Ferritins
1
2020
70
0.040
Why?
Coronavirus
1
2021
47
0.040
Why?
Treatment Failure
1
2021
360
0.040
Why?
Infusions, Intravenous
1
2021
428
0.040
Why?
Signal Transduction
1
2014
5216
0.040
Why?
Polycythemia
1
2020
25
0.040
Why?
Double-Blind Method
1
2025
2062
0.040
Why?
Graft Survival
1
2002
518
0.040
Why?
Software
1
2005
680
0.040
Why?
Outpatients
1
2023
447
0.040
Why?
Hypogonadism
1
2020
93
0.040
Why?
Platelet Glycoprotein GPIb-IX Complex
1
2018
2
0.040
Why?
High-Throughput Screening Assays
1
2021
176
0.040
Why?
Mice, Inbred NOD
1
2020
613
0.040
Why?
Estradiol
1
2022
515
0.040
Why?
Health Care Surveys
1
2020
536
0.030
Why?
Methoxsalen
1
2018
4
0.030
Why?
Phytohemagglutinins
1
2018
29
0.030
Why?
Annexin A5
1
2018
23
0.030
Why?
Methylation
1
2018
242
0.030
Why?
Patient Safety
1
2021
356
0.030
Why?
Developing Countries
1
2020
316
0.030
Why?
Tissue Donors
1
2021
420
0.030
Why?
Child
3
2022
22707
0.030
Why?
Thrombelastography
1
2018
192
0.030
Why?
Cytokines
1
2025
2067
0.030
Why?
Inpatients
1
2021
553
0.030
Why?
Child, Preschool
2
2022
11853
0.030
Why?
Methods
1
2016
68
0.030
Why?
ADP-ribosyl Cyclase 1
1
2016
43
0.030
Why?
Cross Reactions
1
2016
130
0.030
Why?
Antiviral Agents
1
2022
769
0.030
Why?
Blotting, Western
1
2018
1179
0.030
Why?
Logistic Models
1
2021
2134
0.030
Why?
Hemorheology
1
2015
24
0.030
Why?
Erythrocyte Deformability
1
2015
23
0.030
Why?
Nitric Oxide
1
2020
892
0.030
Why?
Biochemistry
1
2015
36
0.030
Why?
Immunoglobulins, Intravenous
1
2016
133
0.030
Why?
Socioeconomic Factors
1
2020
1323
0.030
Why?
Mice, Inbred Strains
1
2016
396
0.030
Why?
Machine Learning
1
2021
587
0.030
Why?
Chromium Radioisotopes
1
2014
4
0.030
Why?
Species Specificity
1
2016
546
0.030
Why?
Perfusion
1
2015
251
0.030
Why?
Antibodies
1
2016
397
0.030
Why?
Genetic Association Studies
1
2016
369
0.030
Why?
Bacterial Infections
1
2016
246
0.030
Why?
Models, Theoretical
2
2009
558
0.020
Why?
Mice, Knockout
1
2021
3124
0.020
Why?
Models, Biological
1
2021
1764
0.020
Why?
Pandemics
1
2021
1707
0.020
Why?
Veterans
1
2025
1635
0.020
Why?
Antioxidants
1
2016
550
0.020
Why?
Case-Control Studies
1
2020
3623
0.020
Why?
Electrophoresis, Gel, Two-Dimensional
1
2012
110
0.020
Why?
Body Mass Index
1
2020
2445
0.020
Why?
Proteomics
1
2018
1188
0.020
Why?
Hospitals
1
2016
732
0.020
Why?
Cell Proliferation
1
2018
2507
0.020
Why?
Cells, Cultured
1
2018
4148
0.020
Why?
Biomarkers
1
2021
4295
0.020
Why?
Drug Therapy, Combination
1
2012
1044
0.020
Why?
Apoptosis
1
2018
2440
0.020
Why?
Emergency Service, Hospital
1
2021
2381
0.020
Why?
Diphosphoglyceric Acids
1
2008
3
0.020
Why?
Alkalies
1
2008
5
0.020
Why?
Aerobiosis
1
2008
18
0.020
Why?
Automation
1
2007
104
0.020
Why?
Risk Factors
1
2021
10885
0.020
Why?
Odds Ratio
1
2009
1082
0.020
Why?
Equipment Design
1
2007
525
0.010
Why?
Acute Lung Injury
1
2009
305
0.010
Why?
Evaluation Studies as Topic
1
2005
164
0.010
Why?
Computer Simulation
1
2009
1003
0.010
Why?
Pilot Projects
1
2008
1891
0.010
Why?
Sepsis
1
2009
664
0.010
Why?
Cohort Studies
1
2009
6013
0.010
Why?
Dumont's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)